Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computer-Assisted Instruction | 3 | 2001 | 21 | 0.480 |
Why?
|
| Multimedia | 2 | 2001 | 12 | 0.350 |
Why?
|
| Education, Medical | 2 | 2001 | 67 | 0.330 |
Why?
|
| Testicular Neoplasms | 2 | 1999 | 17 | 0.280 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 222 | 0.210 |
Why?
|
| Clinical Competence | 1 | 2004 | 307 | 0.200 |
Why?
|
| Educational Status | 1 | 2001 | 164 | 0.190 |
Why?
|
| alpha-Fetoproteins | 1 | 1999 | 7 | 0.180 |
Why?
|
| Germinoma | 1 | 1999 | 2 | 0.180 |
Why?
|
| Patient Education as Topic | 1 | 2001 | 251 | 0.170 |
Why?
|
| Microcomputers | 1 | 1998 | 4 | 0.170 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1998 | 21 | 0.170 |
Why?
|
| User-Computer Interface | 1 | 1998 | 34 | 0.170 |
Why?
|
| Point-of-Care Systems | 1 | 1998 | 33 | 0.160 |
Why?
|
| Anatomy | 1 | 2017 | 5 | 0.160 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2005 | 401 | 0.160 |
Why?
|
| Learning | 1 | 2017 | 76 | 0.150 |
Why?
|
| Physicians | 1 | 1998 | 134 | 0.150 |
Why?
|
| Students, Medical | 1 | 2017 | 121 | 0.140 |
Why?
|
| Computer Simulation | 1 | 1997 | 207 | 0.140 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1994 | 39 | 0.130 |
Why?
|
| Neoplasms | 3 | 2003 | 611 | 0.130 |
Why?
|
| Humans | 18 | 2017 | 29123 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 1995 | 116 | 0.120 |
Why?
|
| Wilms Tumor | 1 | 1993 | 14 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2010 | 1167 | 0.110 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2010 | 3 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 1993 | 192 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 9 | 0.090 |
Why?
|
| Pharyngitis | 1 | 2010 | 11 | 0.090 |
Why?
|
| Streptococcus pyogenes | 1 | 2010 | 17 | 0.090 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 20 | 0.090 |
Why?
|
| Jugular Veins | 1 | 2010 | 26 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 48 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1992 | 337 | 0.090 |
Why?
|
| Leukocytosis | 1 | 2008 | 8 | 0.080 |
Why?
|
| Oxides | 1 | 2008 | 15 | 0.080 |
Why?
|
| Arsenicals | 1 | 2008 | 12 | 0.080 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2008 | 21 | 0.080 |
Why?
|
| Paracentesis | 1 | 2007 | 3 | 0.080 |
Why?
|
| Burkitt Lymphoma | 1 | 2007 | 6 | 0.080 |
Why?
|
| Pleural Effusion | 1 | 2007 | 12 | 0.080 |
Why?
|
| Child | 6 | 2007 | 2219 | 0.080 |
Why?
|
| Male | 9 | 2017 | 17815 | 0.070 |
Why?
|
| Female | 9 | 2017 | 18173 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 546 | 0.070 |
Why?
|
| Curriculum | 2 | 2017 | 196 | 0.070 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2005 | 5 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2005 | 525 | 0.060 |
Why?
|
| Carcinoma | 1 | 2005 | 87 | 0.060 |
Why?
|
| Trust | 1 | 2004 | 39 | 0.060 |
Why?
|
| Religion | 1 | 2003 | 30 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2004 | 134 | 0.060 |
Why?
|
| North Carolina | 2 | 2004 | 1423 | 0.050 |
Why?
|
| Registries | 1 | 2004 | 278 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2004 | 169 | 0.050 |
Why?
|
| Complementary Therapies | 1 | 2003 | 75 | 0.050 |
Why?
|
| Infant | 3 | 2003 | 969 | 0.050 |
Why?
|
| Adolescent | 5 | 2008 | 3255 | 0.050 |
Why?
|
| Adult | 4 | 2017 | 8426 | 0.050 |
Why?
|
| Computer Literacy | 1 | 2001 | 2 | 0.050 |
Why?
|
| Computers | 1 | 2001 | 17 | 0.050 |
Why?
|
| Remission Induction | 2 | 1992 | 78 | 0.050 |
Why?
|
| Communication Barriers | 1 | 2001 | 22 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2001 | 469 | 0.040 |
Why?
|
| Schools, Medical | 1 | 2017 | 42 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 493 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2017 | 84 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 721 | 0.030 |
Why?
|
| Internal Medicine | 1 | 1995 | 44 | 0.030 |
Why?
|
| Medical Oncology | 1 | 1995 | 70 | 0.030 |
Why?
|
| Trisomy | 1 | 1994 | 8 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1994 | 13 | 0.030 |
Why?
|
| Pediatrics | 1 | 1995 | 132 | 0.030 |
Why?
|
| Risk Factors | 1 | 2001 | 3537 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 1993 | 89 | 0.030 |
Why?
|
| United States | 2 | 2003 | 3632 | 0.030 |
Why?
|
| Preoperative Care | 1 | 1993 | 110 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1992 | 246 | 0.030 |
Why?
|
| Young Adult | 1 | 2017 | 2402 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1992 | 440 | 0.020 |
Why?
|
| Hyperuricemia | 1 | 2010 | 12 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 66 | 0.020 |
Why?
|
| Aged | 1 | 2001 | 9492 | 0.020 |
Why?
|
| Thoracic Surgery | 1 | 2007 | 5 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 235 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 2007 | 19 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2010 | 260 | 0.020 |
Why?
|
| Middle Aged | 1 | 2001 | 10834 | 0.020 |
Why?
|
| Prognosis | 1 | 1990 | 1362 | 0.020 |
Why?
|
| Leucovorin | 1 | 2005 | 20 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2005 | 9 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 871 | 0.020 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2005 | 10 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 787 | 0.020 |
Why?
|
| Cisplatin | 1 | 2005 | 69 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2005 | 73 | 0.020 |
Why?
|
| Methotrexate | 1 | 2005 | 60 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1992 | 3101 | 0.020 |
Why?
|
| Survival Rate | 1 | 2005 | 795 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2003 | 391 | 0.010 |
Why?
|